Nanotechnology-based approaches in anticancer research

Area of Science:

• Oncology and Nanomedicine
• Biotechnology and Biomedical Engineering

Background:

• Cancer presents complex diagnostic and therapeutic challenges, with current treatments like chemotherapy, radiation, and surgery having limitations.
• Early cancer detection and precise tumor margin delineation remain significant technological hurdles.
• There is a critical need for advanced technologies to identify residual cancer cells and micrometastases.

Purpose of the Study:

• To review the advancements in nanotechnology-based approaches for cancer diagnostics.
• To summarize the application of nanotechnology in cancer therapeutics.
• To highlight the potential of nanomedicine in overcoming current cancer treatment limitations.

Main Methods:

• Review of recent scientific literature on cancer nanotechnology.
• Analysis of nanoparticle modifications for improved pharmacokinetic and pharmacodynamic properties.
• Synthesis of findings on diagnostic and therapeutic applications of nanomaterials in oncology.

Main Results:

• Nanoparticles can be engineered to improve drug delivery, targeting, and efficacy in cancer treatment.
• Nanotechnology facilitates enhanced visualization for delineating tumor margins and detecting micrometastases.
• Novel nanoparticle-based strategies show promise in overcoming multidrug resistance in cancer.

Conclusions:

• Nanotechnology presents a promising frontier for revolutionizing cancer diagnostics and therapeutics.
• Engineered nanoparticles offer enhanced capabilities for early detection, precise treatment, and improved patient outcomes.
• Continued research in cancer nanotechnology is crucial for developing next-generation oncology solutions.